Seaport Res Ptn Raises Earnings Estimates for Innospec

Innospec Inc. (NASDAQ:IOSP) – Stock analysts at Seaport Res Ptn upped their FY2025 earnings per share (EPS) estimates for Innospec in a report issued on Monday, April 21st. Seaport Res Ptn analyst M. Harrison now expects that the specialty chemicals company will earn $5.75 per share for the year, up from their previous forecast of $5.72. Seaport Res Ptn currently has a “Strong-Buy” rating on the stock. The consensus estimate for Innospec’s current full-year earnings is $6.18 per share. Seaport Res Ptn also issued estimates for Innospec’s Q4 2025 earnings at $1.62 EPS and FY2026 earnings at $6.66 EPS.

Innospec (NASDAQ:IOSP) last issued its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.05. The company had revenue of $466.80 million during the quarter, compared to the consensus estimate of $447.43 million. Innospec had a net margin of 1.93% and a return on equity of 12.27%.

Separately, StockNews.com cut shares of Innospec from a “buy” rating to a “hold” rating in a research report on Wednesday, April 2nd.

Innospec Trading Down 0.6 %

IOSP opened at $89.79 on Thursday. Innospec has a twelve month low of $80.32 and a twelve month high of $133.71. The firm has a market cap of $2.26 billion, a price-to-earnings ratio of 63.23 and a beta of 1.03. The company has a fifty day simple moving average of $94.61 and a 200 day simple moving average of $107.03.

Innospec announced that its board has authorized a stock repurchase program on Monday, March 10th that allows the company to buyback $50.00 million in outstanding shares. This buyback authorization allows the specialty chemicals company to buy up to 2% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.

Insider Activity

In other news, Director Milton C. Blackmore sold 652 shares of the company’s stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $103.30, for a total value of $67,351.60. Following the sale, the director now owns 8,376 shares in the company, valued at approximately $865,240.80. This represents a 7.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Philip John Boon sold 3,754 shares of the stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $103.30, for a total transaction of $387,788.20. Following the transaction, the vice president now directly owns 20,079 shares in the company, valued at $2,074,160.70. The trade was a 15.75 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 7,696 shares of company stock worth $794,853. 1.31% of the stock is currently owned by insiders.

Institutional Trading of Innospec

Several institutional investors and hedge funds have recently bought and sold shares of IOSP. Covestor Ltd increased its holdings in shares of Innospec by 13.9% in the 4th quarter. Covestor Ltd now owns 967 shares of the specialty chemicals company’s stock valued at $106,000 after acquiring an additional 118 shares during the last quarter. Summit Investment Advisors Inc. increased its stake in Innospec by 4.7% during the fourth quarter. Summit Investment Advisors Inc. now owns 2,608 shares of the specialty chemicals company’s stock valued at $287,000 after purchasing an additional 118 shares during the last quarter. PNC Financial Services Group Inc. increased its stake in Innospec by 8.8% during the fourth quarter. PNC Financial Services Group Inc. now owns 1,868 shares of the specialty chemicals company’s stock valued at $206,000 after purchasing an additional 151 shares during the last quarter. New York State Teachers Retirement System lifted its position in shares of Innospec by 1.4% in the 4th quarter. New York State Teachers Retirement System now owns 14,981 shares of the specialty chemicals company’s stock worth $1,649,000 after buying an additional 200 shares during the last quarter. Finally, Inspire Advisors LLC boosted its holdings in shares of Innospec by 3.3% in the 4th quarter. Inspire Advisors LLC now owns 6,704 shares of the specialty chemicals company’s stock valued at $738,000 after buying an additional 213 shares during the period. Institutional investors and hedge funds own 96.64% of the company’s stock.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.